127 related articles for article (PubMed ID: 11815513)
1. Synthetic peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, increases plasma levels of adiponectin in type 2 diabetic patients.
Yang WS; Jeng CY; Wu TJ; Tanaka S; Funahashi T; Matsuzawa Y; Wang JP; Chen CL; Tai TY; Chuang LM
Diabetes Care; 2002 Feb; 25(2):376-80. PubMed ID: 11815513
[TBL] [Abstract][Full Text] [Related]
2. Effect of rosiglitazone on capillary density and angiogenesis in adipose tissue of normoglycaemic humans in a randomised controlled trial.
Gealekman O; Guseva N; Gurav K; Gusev A; Hartigan C; Thompson M; Malkani S; Corvera S
Diabetologia; 2012 Oct; 55(10):2794-2799. PubMed ID: 22847059
[TBL] [Abstract][Full Text] [Related]
3. Agonists of peroxisome-proliferator activated receptor-gamma reduce renal ischemia/reperfusion injury.
Sivarajah A; Chatterjee PK; Patel NS; Todorovic Z; Hattori Y; Brown PA; Stewart KN; Mota-Filipe H; Cuzzocrea S; Thiemermann C
Am J Nephrol; 2003; 23(4):267-76. PubMed ID: 12840602
[TBL] [Abstract][Full Text] [Related]
4. Insulinotropic and anti-inflammatory effects of rosiglitazone in experimental autoimmune diabetes.
Awara WM; el-Sisi AE; el-Refaei M; el-Naa MM; el-Desoky K
Rev Diabet Stud; 2005; 2(3):146-56. PubMed ID: 17491689
[TBL] [Abstract][Full Text] [Related]
5. Restoring adiponectin via rosiglitazone ameliorates tissue wasting in mice with lung cancer.
Langer HT; Ramsamooj S; Dantas E; Murthy A; Ahmed M; Hwang SK; Grover R; Pozovskiy R; Liang RJ; Queiroz AL; Brown JC; White EP; Janowitz T; Goncalves AMD
bioRxiv; 2023 Aug; ():. PubMed ID: 37577571
[TBL] [Abstract][Full Text] [Related]
6. A Precision Medicine Approach to Treating Alzheimer's Disease Using Rosiglitazone Therapy: A Biomarker Analysis of the REFLECT Trials.
O'Bryant SE; Zhang F; Petersen M; Johnson L; Hall J; Rissman RA
J Alzheimers Dis; 2021; 81(2):557-568. PubMed ID: 33814447
[TBL] [Abstract][Full Text] [Related]
7. Imaging and peroxisome proliferator-activated receptor agonists: uncovering their role in atherosclerosis development.
Nissen SE
Clin Cardiol; 2004 Jul; 27(7 Suppl 4):IV17-20. PubMed ID: 15470907
[TBL] [Abstract][Full Text] [Related]
8. Restoring adiponectin via rosiglitazone ameliorates tissue wasting in mice with lung cancer.
Langer HT; Ramsamooj S; Dantas E; Murthy A; Ahmed M; Ahmed T; Hwang SK; Grover R; Pozovskiy R; Liang RJ; Queiroz AL; Brown JC; White EP; Janowitz T; Goncalves MD
Acta Physiol (Oxf); 2024 May; ():e14167. PubMed ID: 38779820
[TBL] [Abstract][Full Text] [Related]
9. Presurgery health influences outcomes following vertical sleeve gastrectomy in adolescents.
Swertfeger D; Kim A; Sexmith H; Moreno-Fernandez ME; Davidson WS; Helmrath M; Jenkins T; Okura T; Geh E; Xanthakos SA; Szabo S; Nakamura T; Divanovic S; Shah AS
Obesity (Silver Spring); 2024 Jun; 32(6):1187-1197. PubMed ID: 38664233
[TBL] [Abstract][Full Text] [Related]
10. Translational control of murine adiponectin expression by an upstream open reading frame element.
Vasu K; Ramachandiran I; Chechi A; Khan K; Khan D; Kaufman R; Fox PL
RNA Biol; 2023 Jan; 20(1):737-749. PubMed ID: 37702393
[TBL] [Abstract][Full Text] [Related]
11. Genetic and Functional Effects of Adiponectin in Type 2 Diabetes Mellitus Development.
Tang YH; Wang YH; Chen CC; Chan CJ; Tsai FJ; Chen SY
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362336
[TBL] [Abstract][Full Text] [Related]
12. A longitudinal analysis of serum adiponectin levels and bone mineral density in postmenopausal women in Taiwan.
Tai TY; Chen CL; Tsai KS; Tu ST; Wu JS; Yang WS
Sci Rep; 2022 May; 12(1):8090. PubMed ID: 35577842
[TBL] [Abstract][Full Text] [Related]
13. Effect of fabrication parameters on morphology and drug loading of polymer particles for rosiglitazone delivery.
Spetz MR; Isely C; Gower RM
J Drug Deliv Sci Technol; 2021 Jul; 65(1-2):. PubMed ID: 35096148
[TBL] [Abstract][Full Text] [Related]
14. The forgotten type 2 diabetes mellitus medicine: rosiglitazone.
Xu B; Xing A; Li S
Diabetol Int; 2022 Jan; 13(1):49-65. PubMed ID: 35059243
[TBL] [Abstract][Full Text] [Related]
15. Puberty Status Modifies the Effects of Genetic Variants, Lifestyle Factors and Their Interactions on Adiponectin: The BCAMS Study.
Wu Y; Zhong L; Li G; Han L; Fu J; Li Y; Li L; Zhang Q; Guo Y; Xiao X; Qi L; Li M; Gao S; Willi SM
Front Endocrinol (Lausanne); 2021; 12():737459. PubMed ID: 35002951
[TBL] [Abstract][Full Text] [Related]
16. Current Status and Future Perspectives on Therapeutic Potential of Apigenin: Focus on Metabolic-Syndrome-Dependent Organ Dysfunction.
Alam W; Rocca C; Khan H; Hussain Y; Aschner M; De Bartolo A; Amodio N; Angelone T; Cheang WS
Antioxidants (Basel); 2021 Oct; 10(10):. PubMed ID: 34679777
[TBL] [Abstract][Full Text] [Related]
17. PPARγ-induced upregulation of subcutaneous fat adiponectin secretion, glyceroneogenesis and BCAA oxidation requires mTORC1 activity.
Andrade ML; Gilio GR; Perandini LA; Peixoto AS; Moreno MF; Castro É; Oliveira TE; Vieira TS; Ortiz-Silva M; Thomazelli CA; Chaves-Filho AB; Belchior T; Chimin P; Magdalon J; Ivison R; Pant D; Tsai L; Yoshinaga MY; Miyamoto S; Festuccia WT
Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Aug; 1866(8):158967. PubMed ID: 34004356
[TBL] [Abstract][Full Text] [Related]
18. Zinc Supplementation Might Not Affect Serum Leptin and Adiponectin Levels in Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials.
Tabatabaie M; Soltani S; Mozaffari-Khosravi H; Salehi-Abargouei A
Iran J Public Health; 2021 Feb; 50(2):245-256. PubMed ID: 33747988
[TBL] [Abstract][Full Text] [Related]
19. Adiponectin, Leptin and Cardiovascular Disorders.
Zhao S; Kusminski CM; Scherer PE
Circ Res; 2021 Jan; 128(1):136-149. PubMed ID: 33411633
[TBL] [Abstract][Full Text] [Related]
20. Age, sex, disease severity, and disease duration difference in placebo response: implications from a meta-analysis of diabetes mellitus.
Lin C; Cai X; Yang W; Lv F; Nie L; Ji L
BMC Med; 2020 Nov; 18(1):322. PubMed ID: 33190640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
